| Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the Dunedin birth cohort study A Caspi, RM Houts, A Ambler, A Danese, ML Elliott, A Hariri, ... JAMA network open 3 (4), e203221-e203221, 2020 | 553 | 2020 |
| Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm DW Belsky, A Caspi, L Arseneault, A Baccarelli, DL Corcoran, X Gao, ... Elife 9, e54870, 2020 | 429 | 2020 |
| Association of neurocognitive and physical function with gait speed in midlife LJH Rasmussen, A Caspi, A Ambler, JM Broadbent, HJ Cohen, ... JAMA network open 2 (10), e1913123-e1913123, 2019 | 152 | 2019 |
| Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation LJH Rasmussen, JEV Petersen, J Eugen-Olsen Frontiers in immunology 12, 780641, 2021 | 143 | 2021 |
| Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study LJH Rasmussen, S Ladelund, TH Haupt, G Ellekilde, JH Poulsen, ... Emergency Medicine Journal 33 (11), 769-775, 2016 | 131 | 2016 |
| Association of adverse experiences and exposure to violence in childhood and adolescence with inflammatory burden in young people LJH Rasmussen, TE Moffitt, L Arseneault, A Danese, J Eugen-Olsen, ... JAMA pediatrics 174 (1), 38-47, 2020 | 130 | 2020 |
| Patterns of reliability: assessing the reproducibility and integrity of DNA methylation measurement K Sugden, EJ Hannon, L Arseneault, DW Belsky, DL Corcoran, HL Fisher, ... Patterns 1 (2), 2020 | 116 | 2020 |
| Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood LJH Rasmussen, TE Moffitt, J Eugen‐Olsen, DW Belsky, A Danese, ... Journal of Child Psychology and Psychiatry 60 (2), 199-208, 2019 | 101 | 2019 |
| Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population TH Haupt, T Kallemose, S Ladelund, LJH Rasmussen, CW Thorball, ... Biomarker insights 9, BMI. S19876, 2014 | 92 | 2014 |
| Adolescents’ perceptions of family social status correlate with health and life chances: A twin difference longitudinal cohort study J Rivenbark, L Arseneault, A Caspi, A Danese, HL Fisher, TE Moffitt, ... Proceedings of the National Academy of Sciences 117 (38), 23323-23328, 2020 | 79 | 2020 |
| Childhood self-control forecasts the pace of midlife aging and preparedness for old age LS Richmond-Rakerd, A Caspi, A Ambler, T d’Arbeloff, M de Bruine, ... Proceedings of the National Academy of Sciences 118 (3), e2010211118, 2021 | 76 | 2021 |
| Association of neighborhood disadvantage in childhood with DNA methylation in young adulthood A Reuben, K Sugden, L Arseneault, DL Corcoran, A Danese, HL Fisher, ... JAMA Network Open 3 (6), e206095-e206095, 2020 | 75 | 2020 |
| Combining national early warning score with soluble urokinase plasminogen activator receptor (suPAR) improves risk prediction in acute medical patients: a registry-based cohort … LJH Rasmussen, S Ladelund, TH Haupt, GE Ellekilde, J Eugen-Olsen, ... Critical care medicine 46 (12), 1961-1968, 2018 | 70 | 2018 |
| Association of history of psychopathology with accelerated aging at midlife J Wertz, A Caspi, A Ambler, J Broadbent, RJ Hancox, HL Harrington, ... JAMA psychiatry 78 (5), 530-539, 2021 | 63 | 2021 |
| Association between elevated suPAR, a new biomarker of inflammation, and accelerated aging LJH Rasmussen, A Caspi, A Ambler, A Danese, M Elliott, J Eugen-Olsen, ... The Journals of Gerontology: Series A 76 (2), 318-327, 2021 | 58 | 2021 |
| Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer LJH Rasmussen, M Schultz, A Gaardsting, S Ladelund, P Garred, ... International journal of cancer 141 (1), 191-199, 2017 | 55 | 2017 |
| Healthy lifestyles reduce suPAR and mortality in a Danish general population study TH Haupt, LJH Rasmussen, T Kallemose, S Ladelund, O Andersen, ... Immunity & Ageing 16, 1-12, 2019 | 50 | 2019 |
| A collaborative medication review including deprescribing for older patients in an emergency department: a longitudinal feasibility study MB Houlind, AL Andersen, C Treldal, LM Jørgensen, PN Kannegaard, ... Journal of Clinical Medicine 9 (2), 348, 2020 | 38 | 2020 |
| Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III) M Schultz, LJH Rasmussen, MH Andersen, JS Stefansson, AC Falkentoft, ... Scandinavian journal of trauma, resuscitation and emergency medicine 26, 1-10, 2018 | 38 | 2018 |
| Early discharge from the emergency department based on soluble urokinase plasminogen activator receptor (suPAR) levels: a TRIAGE III substudy M Schultz, LJH Rasmussen, T Høi-Hansen, E Kjøller, BN Jensen, ... Disease markers 2019 (1), 3403549, 2019 | 36 | 2019 |
